Bibliographic Info
GuidelineUpdate of the Mental Health Gap Action Programme (mhGAP) guidelines for mental, neurological and substance use disorders, 2015
Year of Publication2015
Issuing InstitutionWorld Health Organization
Recommendation
Status
Updated
Recommended in favor
Conditional
Certainty of evidence
Moderate
Certain newer anti-epileptic medications (lamotrigine, levetiracetam and topiramate) should be offered as add-on therapy in patients with medication resistant convulsive epilepsy. The essential anti-epileptic medications (carbamazepine, phenobarbital, phenytoin, and valproic acid) may be of benefit as add-on therapy in patients with medication resistant convulsive epilepsy.